HomeCompareWXIBF vs GBDC

WXIBF vs GBDC: Dividend Comparison 2026

WXIBF yields 43.48% · GBDC yields 11.85%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GBDC wins by $20.50M in total portfolio value· pulled ahead in Year 5
10 years
WXIBF
WXIBF
● Live price
43.48%
Share price
$4.60
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$279.7K
Annual income
$50,636.72
Full WXIBF calculator →
GBDC
GBDC
● Live price
11.85%
Share price
$12.66
Annual div
$1.50
5Y div CAGR
51.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.78M
Annual income
$16,389,263.41
Full GBDC calculator →

Portfolio growth — WXIBF vs GBDC

📍 GBDC pulled ahead of the other in Year 5

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodWXIBFGBDC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, WXIBF + GBDC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
WXIBF pays
GBDC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

WXIBF
Annual income on $10K today (after 15% tax)
$3,695.65/yr
After 10yr DRIP, annual income (after tax)
$43,041.21/yr
GBDC
Annual income on $10K today (after 15% tax)
$1,007.11/yr
After 10yr DRIP, annual income (after tax)
$13,930,873.90/yr
At 15% tax rate, GBDC beats the other by $13,887,832.69/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of WXIBF + GBDC for your $10,000?

WXIBF: 50%GBDC: 50%
100% GBDC50/50100% WXIBF
Portfolio after 10yr
$10.53M
Annual income
$8,219,950.06/yr
Blended yield
78.08%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on GBDC right now

WXIBF
No analyst data
Altman Z
10.0
Piotroski
9/9
GBDC
Analyst Ratings
6
Buy
5
Hold
Consensus: Buy
Price Target
$14.00
+10.6% upside vs current
Range: $13.00 — $15.00
Altman Z
0.6
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

WXIBF buys
0
GBDC buys
2
PoliticianChamberTickerTypeAmountDate
David P. Joyce🏢 House$GBDC▼ Sell$1,001 - $15,0002023-06-30
David P. Joyce🏢 House$GBDC▼ Sell$15,001 - $50,0002023-06-19
David P. Joyce🏢 House$GBDC▼ Sell$15,001 - $50,0002022-07-14
David P. Joyce🏢 House$GBDC▼ Sell$15,001 - $50,0002022-07-12
Teresa Leger Fernandez🏢 House$GBDC▼ Sell$15,001 - $50,0002021-01-20
David P. Joyce🏢 House$GBDC▲ Buy$1,001 - $15,0002020-02-25
David P. Joyce🏢 House$GBDC▲ Buy$15,001 - $50,0002019-05-30
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricWXIBFGBDC
Forward yield43.48%11.85%
Annual dividend / share$2.00$1.50
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%51.1%
Portfolio after 10y$279.7K$20.78M
Annual income after 10y$50,636.72$16,389,263.41
Total dividends collected$215.5K$20.36M
Payment frequencyquarterlyquarterly
SectorStockBDC

Year-by-year: WXIBF vs GBDC ($10,000, DRIP)

YearWXIBF PortfolioWXIBF Income/yrGBDC PortfolioGBDC Income/yrGap
1$15,048$4,347.83$12,490$1,790.28+$2.6KWXIBF
2$22,216$6,114.52$16,522$3,157.73+$5.7KWXIBF
3$32,207$8,436.54$23,578$5,898.68+$8.6KWXIBF
4$45,893$11,430.77$37,115$11,886.75+$8.8KWXIBF
5← crossover$64,327$15,222.29$66,136$26,423.57$1.8KGBDC
6$88,771$19,941.10$137,257$66,491.44$48.5KGBDC
7$120,704$25,718.32$341,734$194,868.54$221.0KGBDC
8$161,835$32,681.83$1,050,788$685,133.02$889.0KGBDC
9$214,115$40,951.88$4,099,314$2,974,971.01$3.89MGBDC
10$279,740$50,636.72$20,775,530$16,389,263.41$20.50MGBDC

WXIBF vs GBDC: Complete Analysis 2026

WXIBFStock

WuXi Biologics (Cayman) Inc. provides end-to-end solutions and services for biologics discovery, development and manufacturing in the People's Republic of China, North America, Europe, and internationally. The company also engages in the provision of consultation services in relation to the biopharmaceutical technology, international sales contracting services, testing and development of testing technologies, sales and marketing services, and biologics clinical and manufacturing services; production and sale of medicals; vaccine CDMO and related business; and material supplier activities. WuXi Biologics (Cayman) Inc. has strategic partnership with ImmuneOncia Therapeutics, Legochem Biosciences Inc, Worg Pharma, OncoC4, and Exelixis Inc. The company was incorporated in 2014 and is headquartered in Wuxi, China.

Full WXIBF Calculator →

GBDCBDC

Golub Capital BDC, Inc. (GBDC) is a business development company and operates as an externally managed closed-end non-diversified management investment company. It invests in debt and minority equity investments in middle-market companies that are, in most cases, sponsored by private equity investors. It typically invests in diversified consumer services, automobiles, healthcare technology, insurance, health care equipment and supplies, hotels, restaurants and leisure, healthcare providers and services, IT services and specialty retails. It seeks to invest in the United States. It primarily invests in first lien traditional senior debt, first lien one stop, junior debt and equity, senior secured, one stop, unitranche, second lien, subordinated and mezzanine loans of middle-market companies, and warrants.

Full GBDC Calculator →
📬

Get this WXIBF vs GBDC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

WXIBF vs SCHDWXIBF vs JEPIWXIBF vs OWXIBF vs KOWXIBF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.